ロード中...
Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia
METHODS: Pneumocystis carinii pneumonia occasionally appears in immunodeficient patients. While several reports have shown that Pneumocystis carinii pneumonia occurred in the early phase of starting infliximab treatment in patients with Crohn’s disease (CD), the present case suggests for the first t...
保存先:
| 出版年: | Gut Pathog |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4736477/ https://ncbi.nlm.nih.gov/pubmed/26839596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13099-016-0086-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|